Sign In
Buy HRMY
$35.24
-0.620 (-1.73%)
At Close: Jul 31, 2026
HRMY Stock Alert: Scorpion Short Report Sends Harmony Plunging
01:03pm, Tuesday, 28'th Mar 2023
Shares of Harmony Biosciences (NASDAQ: HRMY ) stock are plunging lower by about 25% following a short report from Scorpion Capital. The activist short seller spent four months researching the report,
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
04:13pm, Tuesday, 21'st Mar 2023
Stock market investors have been on a rollercoaster ride over the past year. The Federal Reserve continues to be hawkish in controlling inflation.
Harmony Biosciences: Why I Am Adding More Shares
07:16am, Sunday, 12'th Mar 2023
Today, we circle back on a biopharma name called Harmony Biosciences Holdings. The company recently posted solid fourth quarter results, and the stock seems undervalued after an approximate 30% declin
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
08:05am, Monday, 06'th Mar 2023
PLYMOUTH MEETING, Pa. , March 6, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializ
Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings and Revenues Beat Estimates
12:04am, Wednesday, 22'nd Feb 2023
Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 87.04% and 0.46%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead
Harmony Biosciences Holdings, Inc. (HRMY) Q4 2022 Earnings Call Transcript
02:32pm, Tuesday, 21'st Feb 2023
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY ) Q4 2022 Earnings Conference Call February 21, 2023 8:30 AM ET Company Participants Luis Sanay - Head-Investor Relations Jeffrey Dierks - Chief Commerc
Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings and Revenues Beat Estimates
10:32am, Tuesday, 21'st Feb 2023
Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 87.04% and 0.46%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead
Harmony Biosciences, The No. 3 Biotech, Just Topped Forecasts; But Concerns Persist
09:51am, Tuesday, 21'st Feb 2023
Harmony Biosciences beat quarterly expectations Tuesday, leading the biotech stock to surge despite a barrage of commercial concerns. The post Harmony Biosciences, The No.
The 7 Best Biotech Stocks to Buy for February 2023
01:51pm, Tuesday, 07'th Feb 2023
While unpredictable compared to other sectors due to the ebb and flow of clinical trials, the best biotech stocks to buy offer investors incredible upside opportunities. Better yet, the volatility lar
HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS ON FEBRUARY 21, 2023
08:05am, Tuesday, 07'th Feb 2023
PLYMOUTH MEETING, Pa. , Feb. 7, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (NASDAQ: HRMY), a pharmaceutical company dedicated to developing and commercializin
2 Biotechs Making Waves With A Single Product in their Pipeline
10:10am, Thursday, 12'th Jan 2023
Catalyst Pharmaceuticals and Harmony Bioscience each have a single product in their respective pipelines, and both show incredible promise.
Strength Seen in Harmony Biosciences Holdings, Inc. (HRMY): Can Its 5.1% Jump Turn into More Strength?
09:02am, Wednesday, 11'th Jan 2023
Harmony Biosciences Holdings, Inc. (HRMY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest fu
IPO Stock Leaders Harmony, ProFrac Outperform Despite Tough 2022 Market
12:52pm, Friday, 30'th Dec 2022
Despite a struggling IPO market in 2022, Harmony Biosciences and ProFrac are holding up well in the ongoing stock market correction. The post IPO Stock Leaders Harmony, ProFrac Outperform Despite Toug
HARMONY BIOSCIENCES TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
08:05am, Thursday, 22'nd Dec 2022
PLYMOUTH MEETING, Pa. , Dec. 22, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializi
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
12:24pm, Wednesday, 14'th Dec 2022
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
